AZD-0284 clinical trials
Also written AZD0284.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How each study uses AZD-0284 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- AZD0284
- 3
Studies by the year they started
3 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses AZD-0284 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study to Determine if AZD0284 is Effective and Safe in Treating Plaque PsoriasisTerminatedPhase 1AstraZenecaNCT03310320Written as AZD0284 oral solution 2.5 mg/mL
- Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy SubjectsCompletedPhase 1AstraZenecaNCT02976831Written as AZD0284
- Bioavailability of AZD0284 and IV Microtracer StudyCompletedPhase 1AstraZenecaNCT03029741Written as AZD0284
Codes
What other systems call AZD-0284 · ClinicalTrials.gg INT001750
- MeSH (NLM) C000720454AZD-0284One source NLM
- UNII (FDA) 5G4XF6VU2YAZD-0284One source NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000720454 | AZD-0284 | One source NLM |
| UNII (FDA) | 5G4XF6VU2Y | AZD-0284 | One source NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.